Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways

Journal of Dermatological Science

Volumn 78, Issue 3, 2015, Pages 181-188

  Hu, Feng ^a   Liu, Xin Xin ^a   Wang, Xin ^a   Alashkar, Mohammad ^a   Zhang, Song ^a   Xu, Jun Tao ^a   Zhong, Xue Lian ^a   He, Meng Wen ^a   Feng, Ai Ping ^a   Chen, Hong Xiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell cycle; Cell proliferation; Inflammation; Keratinocyte; Lipoxin A4

Indexed keywords

CHEMOKINE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR RELA; LIPOPOLYSACCHARIDE; LIPOXIN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INHIBITION KINETICS; KERATINOCYTE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE CHECKPOINT; CYTOLOGY; DRUG EFFECTS; EPIDERMIS; GENETICS; IMMUNOLOGY; PHYSIOLOGY;

CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINES; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOKINES; EPIDERMIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; LIPOPOLYSACCHARIDES; LIPOXINS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84929043933     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.03.009     Document Type: Article

References (44)

1. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
2. Walker J., Dichter E., Lacorte G., Kerner D., Spur B., Rodriguez A., et al. Lipoxin A4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 2011, 36:410-416.
3. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007, 25:101-137.
4. Machado F.S., Johndrow J.E., Esper L., Dias A., Bafica A., Serhan C.N., et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 2006, 12:330-334.
5. Brancaleone V., Gobbetti T., Cenac N., le Faouder P., Colom B., Flower R.J., et al. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood 2013, 122:608-617.
6. McMahon B., Mitchell D., Shattock R., Martin F., Brady H.R., Godson C. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 2002, 16:1817-1819.
7. Shimizu S., Ogawa T., Seno S., Kouzaki H., Shimizu T. Pro-resolution mediator lipoxin A4 and its receptor in upper airway inflammation. Ann Otol Rhinol Laryngol 2013, 122:683-689.
8. Wu S.H., Lu C., Dong L., Zhou G.P., He Z.G., Chen Z.Q. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. Kidney Int 2005, 68:35-46.
9. Wu S.H., Wu X.H., Lu C., Dong L., Chen Z.Q. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am J Respir Cell Mol Biol 2006, 34:65-72.
10. Leibold J.S., Riehl A., Hettinger J., Durben M., Hess J., Angel P. Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo. J Invest Dermatol 2013, 133:2400-2406.
11. Hyter S., Indra A.K. Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis. FEBS Lett 2013, 587:529-541.
12. Albanesi C., Pastore S. Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Curr Drug Metab 2010, 11:210-227.
13. Kemp M.W., Saito M., Nitsos I., Jobe A.H., Kallapur S.G., Newnham J.P. Exposure to in utero lipopolysaccharide induces inflammation in the fetal ovine skin. Reprod Sci 2011, 18:88-98.
14. Nagy I., Pivarcsi A., Koreck A., Szell M., Urban E., Kemeny L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol 2005, 124:931-938.
15. Chen H., Takahara M., Xie L., Takeuchi S., Tu Y., Nakahara T., et al. Lipoxin A(4), a potential anti-inflammatory drug targeting the skin. J Dermatol Sci 2011, 62:67-69.
16. Colonna M. AHR: making the keratinocytes thick skinned. Immunity 2014, 40:863-864.
17. Wang S.S., Kamphuis W., Huitinga I., Zhou J.N., Swaab D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry 2008, 13(741):786-799.
18. Boeuf P., Vigan-Womas I., Jublot D., Loizon S., Barale J.C., Akanmori B.D., et al. CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 2005, 6(5).
19. Drew J.E., Mayer C.D., Farquharson A.J., Young P., Barrera L.N. Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue. J Mol Diagn 2011, 13:233-242.
20. Taube M.E., Liu X.W., Fridman R., Kim H.R. TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein. Oncogene 2006, 25:3041-3048.
21. Tolg C., Sabha N., Cortese R., Panchal T., Ahsan A., Soliman A., et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab Invest 2011, 91:825-836.
22. Aliberti J., Hieny S., Reis e Sousa C., Serhan C.N., Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 2002, 3:76-82.
23. Olaya J., Neopikhanov V., Uribe A. Lipopolysaccharide of Escherichia coli, polyamines, and acetic acid stimulate cell proliferation in intestinal epithelial cells. In Vitro Cell Dev Biol Anim 1999, 35:43-48.
24. Goodier M.R., Londei M. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. J Immunol 2000, 165:139-147.
25. Preciado D., Caicedo E., Jhanjee R., Silver R., Harris G., Juhn S.K., et al. Pseudomonas aeruginosa lipopolysaccharide induction of keratinocyte proliferation, NF-kappa B, and cyclin D1 is inhibited by indomethacin. J Immunol 2005, 174:2964-2973.
26. Albanesi C., Scarponi C., Giustizieri M.L., Girolomoni G. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005, 4:329-334.
27. Barker J.N., Sarma V., Mitra R.S., Dixit V.M., Nickoloff B.J. Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 1990, 85:605-608.
28. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006, 24:317-327.
29. Zepter K., Haffner A., Soohoo L.F., De Luca D., Tang H.P., Fisher P., et al. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 1997, 159:6203-6208.
30. Homey B., Dieu-Nosjean M.C., Wiesenborn A., Massacrier C., Pin J.J., Oldham E., et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000, 164:6621-6632.
31. Huang Y.H., Wang H.M., Cai Z.Y., Xu F.Y., Zhou X.Y. Lipoxin A4 inhibits NF-kappaB activation and cell cycle progression in RAW264.7 cells. Inflammation 2014, 37:1084-1090.
32. Musgrove E.A., Lee C.S., Buckley M.F., Sutherland R.L. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci U S A 1994, 91:8022-8026.
33. Quelle D.E., Ashmun R.A., Shurtleff S.A., Kato J.Y., Bar-Sagi D., Roussel M.F., et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993, 7:1559-1571.
34. Geradts J., Wilson P.A. High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol 1996, 149:15-20.
35. Tatemichi M., Hata H., Tazawa H., Nakadate T. Lipopolysaccharide induces aberrant hypermethylation of Hic-1 in mouse embryonic fibroblasts lacking p53 gene. Anticancer Res 2008, 28:2101-2108.
36. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001, 107:7-11.
37. Haller D., Holt L., Parlesak A., Zanga J., Bauerlein A., Sartor R.B., et al. Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology 2004, 112:310-320.
38. Potapovich A.I., Lulli D., Fidanza P., Kostyuk V.A., De Luca C., Pastore S., et al. Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFkappaB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol 2011, 255:138-149.
39. Luo C.L., Li Q.Q., Chen X.P., Zhang X.M., Li L.L., Li B.X., et al. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury. Brain Res 2013, 1502:1-10.
40. Cezar-de-Mello P.F., Vieira A.M., Nascimento-Silva V., Villela C.G., Barja-Fidalgo C., Fierro I.M. ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor. Br J Pharmacol 2008, 153:956-965.
41. Wang Y.P., Wu Y., Li L.Y., Zheng J., Liu R.G., Zhou J.P., et al. Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-kappaB and MAPKs in BV-2 microglial cells. J Neuroinflammation 2011, 8:(95).
42. Lavoie J.N., L'Allemain G., Brunet A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996, 271:20608-20616.
43. Wang X., Sun D.F., Lu R., Chen Z.F., Chen Y.X., Fang J.Y. RAF may induce cell proliferation through hypermethylation of tumor suppressor gene promoter in gastric epithelial cells. Cancer Sci 2009, 100:117-125.
44. Wen-Sheng W. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene 2003, 22:955-963.